Who is sponsoring NCT02403583?

NCT02403583 is sponsored by University of Alabama at Birmingham.

What drugs are being tested in NCT02403583?

Interventions in NCT02403583: Intervention- Home Visits.

What condition does NCT02403583 study?

NCT02403583 studies Human Immunodeficiency Virus.

Is NCT02403583 still recruiting?

NCT02403583 is currently completed. Last updated 6 April 2017.

Last reviewed 2017-04-06 · How we verify

NCT02403583

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jamii Bora: A Home-Based Couples Intervention

Completed NA Last updated 6 April 2017

What this trial tests

NA trial testing Intervention- Home Visits in Human Immunodeficiency Virus in 233 participants. Completed in 31 March 2017.

Timeline

1 August 2014

Primary endpoint
31 March 2017

31 March 2017

Quick facts

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	233
Start date	1 August 2014
Primary completion	31 March 2017
Estimated completion	31 March 2017
Sites	5 locations across Kenya

Drugs / interventions tested

Intervention- Home Visits

Conditions studied

Human Immunodeficiency Virus — all drugs for Human Immunodeficiency Virus →

Sponsor

University of Alabama at Birmingham

Who can join

18 and older, any sex, with Human Immunodeficiency Virus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to develop and pilot-test a home-based intervention to facilitate sate HIV testing and disclosure within pregnant couples in order to increase use of prevention-of-mother-to-child-transmission (PMTCT) and family health services in Kenya.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Development and Piloting of a Home-Based Couples Intervention During Pregnancy and Postpartum in Southwestern Kenya.
Turan JM, Darbes LA, Musoke PL, Kwena Z, et al · · 2018 · cited 47× · PMID 29620927 · DOI 10.1089/apc.2017.0285
The role of women's empowerment and male engagement in pregnancy healthcare seeking behaviors in western Kenya.
Bello FO, Musoke P, Kwena Z, Owino GO, et al · · 2019 · cited 11× · PMID 30727846 · DOI 10.1080/03630242.2019.1567644
Effects of a Home-Based Intervention on HIV Prevention Health Behaviors in Pregnant/Postpartum Kenyan Women: Estimating Moderating Effects of Depressive Symptoms.
Anderson JL, Li P, Bukusi EA, Darbes LA, et al · · 2021 · cited 5× · PMID 33057976 · DOI 10.1007/s10461-020-03046-2

Verify or expand the search:

Other recruiting trials for Human Immunodeficiency Virus

Currently open trials in the same condition.

NCT07530198 — HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong · Phase 1 · recruiting
NCT06819176 — Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir · Phase 1 · recruiting
NCT06408142 — Universal Test and Connect for HIV Service Delivery in South Africa · recruiting
NCT07101458 — The Eswatini PRISM Study on Adolescents Living With HIV · NA · recruiting
NCT06554223 — The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care · NA · recruiting

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02403583 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 6 April 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02403583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing